Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -4.62% is 92% above its 5-year average of -55.35%, near the high end of its 5-year range (-113.28%–-4.62%).
As of the fiscal period ended Tuesday, June 30, 2026. 68.39% above its 12-month average of -14.63%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -4.62%.
RETURN ON INVESTED CAPITAL (ROIC)
-4.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-14.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-32.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-55.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+68.39%
CURRENT VS 3Y AVG
+85.68%
CURRENT VS 5Y AVG
+91.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 652 covered companies
CURRENT VS SECTOR MEDIAN
+86.24%
vs the sector median at left
Clover Health Investments, Corp.
Market Cap
$2.42B
Return on Invested Capital (ROIC)
-4.62%
TTM Avg
-14.63%
3Y Avg
-32.31%
5Y Avg
-55.35%
Market Cap
$2.43B
Return on Invested Capital (ROIC)
-26.95%
TTM Avg
-26.95%
3Y Avg
-26.95%
5Y Avg
-26.95%
Market Cap
$2.41B
Return on Invested Capital (ROIC)
-49.78%
TTM Avg
-43.13%
3Y Avg
-47.40%
5Y Avg
-42.10%
Market Cap
$2.39B
Return on Invested Capital (ROIC)
27.60%
TTM Avg
29.86%
3Y Avg
13.68%
5Y Avg
-0.60%
Market Cap
$2.38B
Return on Invested Capital (ROIC)
-77.92%
TTM Avg
-42.31%
3Y Avg
-48.27%
5Y Avg
-40.00%
Market Cap
$2.47B
Return on Invested Capital (ROIC)
-38.21%
TTM Avg
-29.01%
3Y Avg
-27.76%
5Y Avg
-29.57%
Market Cap
$2.36B
Return on Invested Capital (ROIC)
46.99%
TTM Avg
-39.61%
3Y Avg
-45.77%
5Y Avg
-48.25%
Market Cap
$2.31B
Return on Invested Capital (ROIC)
14.96%
TTM Avg
15.56%
3Y Avg
18.20%
5Y Avg
16.63%
Market Cap
$2.29B
Return on Invested Capital (ROIC)
16.96%
TTM Avg
-12.78%
3Y Avg
-0.83%
5Y Avg
5.59%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. (CLOV) | $2.42B | -4.62% | -14.63% | -32.31% | -55.35% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.43B | -26.95% | -26.95% | -26.95% | -26.95% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.41B | -49.78% | -43.13% | -47.40% | -42.10% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.39B | 27.60% | 29.86% | 13.68% | -0.60% |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.38B | -77.92% | -42.31% | -48.27% | -40.00% |
| Disc Medicine, Inc. (IRON)vs › | $2.47B | -38.21% | -29.01% | -27.76% | -29.57% |
| Liquidia Corporation (LQDA)vs › | $2.36B | 46.99% | -39.61% | -45.77% | -48.25% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.31B | 14.96% | 15.56% | 18.20% | 16.63% |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.29B | 16.96% | -12.78% | -0.83% | 5.59% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.63B | -38.70% | -28.14% | -29.66% | -30.84% |
ROIC
-4.6%
ROE
-4.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -4.62% |
| 2026-03-31 | -15.76% |
| 2025-12-31 | -25.75% |
| 2025-09-30 | -15.74% |
| 2025-06-30 | -11.28% |
| 2025-03-31 | -6.61% |
| 2024-12-31 | -12.46% |
| 2024-09-30 | -24.09% |
| 2024-06-30 | -32.83% |
| 2024-03-31 | -47.83% |
| 2023-12-31 | -67.15% |
| 2023-09-30 | -73.10% |
| 2023-06-30 | -82.75% |
| 2023-03-31 | -105.96% |
| 2022-12-31 | -98.50% |
| 2022-09-30 | -105.07% |
| 2022-06-30 | -113.28% |
| 2022-03-31 | -99.43% |
| 2021-12-31 | -110.17% |
| 2021-09-30 | -71.70% |
| 2021-06-30 | -38.25% |
| 2021-03-31 | -25.88% |
| 2020-12-31 | -74.87% |
| 2020-09-30 | -7.69% |
| 2020-06-30 | -10.40% |
| 2019-12-31 | -119030.78% |
